Trevi Therapeutics (TRVI) Interest & Investment Income (2023 - 2025)

Trevi Therapeutics' Interest & Investment Income history runs 3 years deep, the most recent figure standing at $1.9 million for Q4 2025.

• On a quarterly basis, Interest & Investment Income rose 125.74% year-over-year to $1.9 million in Q4 2025; TTM through Dec 2025 was $6.3 million, a 73.63% increase from a year earlier, with the FY2025 full-year figure at $6.5 million, up 81.45% from the prior year.
• Interest & Investment Income declined to $1.9 million in Q4 2025 per TRVI's latest filing, from $2.1 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $2.1 million in Q3 2025 and bottomed at $826000.0 in Q3 2024.
• The 3-year median for Interest & Investment Income is $1.1 million (2023), against an average of $1.3 million.
• Across the five-year window, Interest & Investment Income plunged 30.18% in 2024 and jumped 154.36% in 2025, its largest moves.
• Year by year, Interest & Investment Income stood at $1.1 million in 2023, then fell by 25.86% to $843000.0 in 2024, then surged by 125.74% to $1.9 million in 2025.
• Per Business Quant, the three latest TRVI Interest & Investment Income figures stand at $1.9 million (Q4 2025), $2.1 million (Q3 2025), and $1.4 million (Q2 2025).